X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

期刊標題檢索 JAIDS-J ACQ IMM 最新評論: The discussion section is the core part of a SCI paper, as it can dem... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES]您好,您是該頁面的第 28316 位訪客。

期刊簡介
期刊名稱JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LetPub Score
7.4
50 ratings
Rate

Reputation
8.7

Influence
6.4

Speed
7.0

期刊簡稱JAIDS-J ACQ IMM DEF
ISSN1525-4135
E-ISSN1944-7884
h-index142
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.801.2250.917
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q284 / 272
Category: Medicine
Subcategory: Infectious Diseases
Q2119 / 344

自引率 (2023-2024)3.40%自引率趨勢
掲載範囲
JAIDS: Journal of Acquired Immune Deficiency Syndromes​ seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide.


JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.
官方網站http://journals.lww.com/jaids/pages/default.aspx
在線稿件提交https://www.editorialmanager.com/JAIDS
開放訪問No
出版商Lippincott Williams and Wilkins Ltd.
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1999
每年文章數187每年文章數趨勢
黃金OA百分比17.40%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ3108/181
INFECTIOUS DISEASESSCIEQ258/132
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1525-4135%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-6 Week(s)
競爭力 *來自作者的數據: Difficult
參考鏈接
相關期刊 【JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    LANCET INFECTIOUS DISEASESH-index: 201

    CiteScore: 60.90
    JOURNAL OF INFECTIONH-index: 90

    CiteScore: 45.90
    CLINICAL MICROBIOLOGY AND INFECTIONH-index: 131

    CiteScore: 25.30
    CLINICAL INFECTIOUS DISEASESH-index: 303

    CiteScore: 25.00
    EMERGING INFECTIOUS DISEASESH-index: 202

    CiteScore: 17.30
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICAH-index: 84

    CiteScore: 8.30
    INFECTIONH-index: 66

    CiteScore: 12.50
    JOURNAL OF INFECTIOUS DISEASESH-index: 231

    CiteScore: 13.50
    International Journal of Antimicrobial AgentsH-index: 111

    CiteScore: 21.60
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASESH-index: 73

    CiteScore: 18.90
    學科內最受檢索的期刊 頁面查看次數
    BMC INFECTIOUS DISEASES105620
    JOURNAL OF INFECTIOUS DISEASES100477
    JOURNAL OF INFECTION93563
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES83357
    CLINICAL INFECTIOUS DISEASES79992
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY68771
    International Journal of Antimicrobial Agents67929
    Transboundary and Emerging Diseases67522
    EMERGING INFECTIOUS DISEASES66515
    INFECTION AND IMMUNITY65810
  •  

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES] 的評論撰寫評論
作者: Unjutty


領域:
審稿時間: 4.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-24 08:17:31 評論於
 (0) 讚! | Unjutty  

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 14:51:07 評論於
The discussion section is the core part of a SCI paper, as it can demonstrate the breadth and depth of the author's research. Therefore, there is no specific word limit for this section. Different articles by different authors will have varying lengths for the discussion section, ranging from a few thousand words to tens of thousands of words
(0) 讚! | 维尔娜菲茨杰拉德

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 20:41:59 評論於
Does the lengthy discussion demonstrate the author's reflection on the topic? Did the reviewers have a favorable impression of the manuscript?
(0) 讚! | 北国博达

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 19:35:57 評論於
What is IF?
(0) 讚! | 陶宜三岁啦

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-04-05 19:44:13 評論於
It is a domineering and shameless magazine that rejects articles directly based on the opinion of an irresponsible reviewer. The specific situation is: previously, with a colleague, we submitted an article on molecular epidemiology, led by the colleague. We then conducted an evolutionary analysis using the sequences from this article and sequences from other articles, discovering some new results. The accepted article and the submitted article were completely different in terms of research content, but just because we used the sequences from the accepted article, we were accused by the reviewer of duplicate publication. Angered, I wrote a rebuttal, and after about 6 days, the editor actually said "It is our journal policy that we do not reverse our editorial decision based on honest disagreements." I don't know what "honest disagreements" even means
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-04-05 18:59:46 評論於
It is a domineering magazine, which directly rejects the submission based solely on the opinion of an irresponsible reviewer. The specific situation is: we previously collaborated with an author to submit an article on molecular epidemiology, with the author as the lead. We then used the sequences of this article, as well as sequences from other articles, to conduct evolutionary analysis and discovered some new results. The accepted article and the submitted article were completely different in terms of research content, but because we used sequences from the accepted article, we were wrongly accused by the reviewer of duplicate publication. Out of anger, we wrote a rebuttal, attached the pdf of our accepted article, and the article currently submitted for review, for the editor and reviewer to compare to determine if we were indeed guilty of duplicate publication. After about 6 days, the editor unexpectedly said, "It is our journal policy that we do not reverse our editorial decision based on honest disagreements." I don't know what "honest disagreements" means
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2010-07-06 22:22:37 評論於
Too difficult, try 5 times fail 5 times
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2010-07-06 14:46:56 評論於
Submitted once, it was rejected without passing the editorial review, saying it did not meet the magazine's standards. They probably don't appreciate Chinese articles
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*